RUNX3 and neoplasm: Despite studies analyzing pre-invasive [8,23,24] and invasive carcinomas [25,26,27], which were performed in diverse tumor types, the mechanisms by which aberrant RUNX3 expression impacts disease pathogenesis remains poorly understood.